Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
WHITE HOUSE AND THE WORLD POLICY BRIEFS
December 03, 2020
Swift and orderly action on international debt is a moral, political, economic, and security imperative for the United States. A series of disorderly and protracted debt crises would be catastrophic for the world’s poorest countries. A Biden administration can raise the G20’s ambition level to avert...
Blog Post
October 05, 2020
There are three critical and urgent issues that should rise to the top of the agenda for the upcoming meetings of the G20 and the IMF and World Bank. IMF shareholders should seize the moment to give the Fund a mandate to develop feasible but fit-for-purpose proposals in these areas.
Blog Post
July 07, 2020
Philippe Le Houerou, the Chief Executive of the IFC has announced his intention to step down in September. His legacy will include a significant effort to focus the work of the corporation on development impact and the world’s poorest countries. Le Houerou has had some success. But a look ...
Blog Post
July 06, 2020
Imagine the young George Washington said, “I cannot tell a lie. I did not cut down the cherry tree,” then added sotto voce, “’twas the hatchet that did it.” Multilateral development banks (MDBs) and development finance institutions are dissembling in the other direction when it comes to their impact...
CGD NOTES
May 05, 2020
Much of the policy debate regarding COVID-19 medical equipment focuses on the question of which form of patient respiratory support is effective in low-resources settings. However, irrespective of the specific form of respiratory support used, the long-term and cost-effective functioning of all form...
CGD NOTES
February 06, 2020
Over the past two decades, global health innovation has delivered important new tools for use in low- and middle-income countries (LMICs) and saved many lives. Nonetheless, the current innovation ecosystem suffers from significant limitations that are likely to worsen with aid transition.
Blog Post
January 23, 2020
As middle income countries transition from donor support and increasingly use domestic funds to finance health programmes that have previously received substantial external aid, it is imperative that they build and use Health Technology Assessment capacities so that they can prioritise inv...